Reverse Translational Research of ABCG2 (BCRP) in Human Disease and Drug Response

E-ISSN： 1532-6535|103|2|233-242

ISSN： 0009-9236

Source： CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol.103, Iss.2, 2018-02, pp. : 233-242

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Genome‐wide association study identifies ABCG2 (BCRP) as an allopurinol transporter and a determinant of drug response

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 97, Iss. 5, 2015-05 ,pp. : 518-525

John Wiley & Sons Inc

Access to resources Recommend Favorite

Drug Research and Translational Bioinformatics

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 91, Iss. 6, 2012-06 ,pp. : 960-962

John Wiley & Sons Inc

Access to resources Recommend Favorite

Reverse and Forward Translational Neuropharmacology in Psychiatric Drug Discovery

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 103, Iss. 2, 2018-02 ,pp. : 193-195

John Wiley & Sons Inc

Access to resources Recommend Favorite

An ATP-binding cassette gene (ABCG5) from the ABCG (White) gene subfamily maps to human chromosome 2p21 in the region of the Sitosterolemia locus

Cytogenetic and Genome Research, Vol. 92, Iss. 3-4, 2001-06 ,pp. : 204-208

Karger

Access to resources Recommend Favorite

Translational Research

INTERNATIONAL JOURNAL OF STROKE, Vol. 10, Iss. S5, 2015-12 ,pp. : 66-67

John Wiley & Sons Inc

Access to resources Recommend Favorite